Charles Theuer

Halozyme

BIOGRAPHY

Dr. Charles Theuer is the Chief Medical Officer at Halozyme, where he leads clinical strategy for subcutaneous drug delivery programs using ENHANZE® technology and auto-injector platforms. He brings deep experience in oncology and therapeutic innovations, having held executive and clinical leadership roles across major biotech companies.

Charles previously served as the CEO and CMO of TRACON Pharmaceuticals and directed the development of several landmark cancer therapies. His career reflects a consistent focus on improving patient outcomes and advancing precision medicine through global partnerships.